TARO-CALCITRIOL DIN 02485729
Health Canada record
| Active ingredient(s) | CALCITRIOL 0.5 MCG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A11CC04 CALCITRIOL |
| Original market date | 03-Jun-2019 |
| Current status date | 03-Jun-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CALCITRIOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02431645 | CALCITRIOL-ODAN | ODAN LABORATORIESLTD | Capsule | CALCITRIOL 0.5 MCG | Marketed |
| 02431637 | CALCITRIOL-ODAN | ODAN LABORATORIESLTD | Capsule | CALCITRIOL 0.25 MCG | Marketed |
| 00481823 | ROCALTROL | SEARCHLIGHT PHARMA INC | Capsule | CALCITRIOL 0.25 MCG | Marketed |
| 00481815 | ROCALTROL | SEARCHLIGHT PHARMA INC | Capsule | CALCITRIOL 0.5 MCG | Marketed |
| 02485710 | TARO-CALCITRIOL | TARO PHARMACEUTICALS INC | Capsule | CALCITRIOL 0.25 MCG | Marketed |
| 00891746 | CALCIJEX | ABBVIE CORPORATION | Solution | CALCITRIOL 2 MCG | Cancelled Post Market |
| 00891738 | CALCIJEX | ABBVIE CORPORATION | Solution | CALCITRIOL 1 MCG | Cancelled Post Market |
| 02245686 | CALCITRIOL INJECTION | FRESENIUS KABI CANADA LTD | Solution | CALCITRIOL 1 MCG | Cancelled Post Market |
| 02399334 | CALCITRIOL INJECTION USP | STERIMAX INC | Solution | CALCITRIOL 1 MCG | Dormant |
| 02399342 | CALCITRIOL INJECTION USP | STERIMAX INC | Solution | CALCITRIOL 2 MCG | Dormant |
| 02495899 | PMS-CALCITRIOL | PHARMASCIENCE INC | Capsule | CALCITRIOL 0.25 MCG | Dormant |
| 02495902 | PMS-CALCITRIOL | PHARMASCIENCE INC | Capsule | CALCITRIOL 0.5 MCG | Dormant |
| 00824291 | ROCALTROL ORAL SOLUTION 1MCG/ML | HOFFMANN-LA ROCHE LIMITED | Solution | CALCITRIOL 1 MCG | Cancelled Post Market |
| 02338572 | SILKIS | GALDERMA CANADA INC. | Ointment | CALCITRIOL 3 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21861 | 2019-02-12 | Abbreviated New Drug Submission (ANDS) |
International API supply for CALCITRIOL
6 valid EDQM Certificates of Suitability from 6 holders. 5 active FDA Drug Master Files.
Request a quote for TARO-CALCITRIOL